Back to search

Article

Proteomic analysis provides insights into the molecular regulatory mechanism of Dengzhan Shengmai capsule in a rat model of vascular dementia

2022-08-09

Abstract excerpt

Dengzhan Shengmai (DZSM) capsule is a compound Chinese medicine that is widely used in the clinic for the treatment of ischemic cerebrovascular diseases along with symptoms of dementia and forgetfulness. DZSM can improve the cognitive function and quality of life of patients with vascular dementia (VD), but little is known about the therapeutic mechanisms. In this study, we found that DZSM rescued spatial memory i...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
39b4ebff-b473-5ba5-a5fe-fe2196214ddd
DOI
10.21203/rs.3.rs-1931304/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Proteomic analysis provides insights into the molecular regulatory mechanism of Dengzhan Shengmai capsule in a rat model of vascular dementiaDOI 10.21203/rs.3.rs-1931304/v1
Select a neighboring publication to make it the new centre.